Journey Medical Corp (DERM)
7.03
+0.15
(+2.18%)
USD |
NASDAQ |
May 02, 16:00
6.99
-0.04
(-0.57%)
After-Hours: 20:00
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 162.42M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 93.66% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 2.555 |
| Price to Book Value | 8.093 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 1.240 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | -- |
Profile
Edit
| Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others. |
| URL | https://www.journeymedicalcorp.com |
| Investor Relations URL | N/A |
| HQ State/Province | Arizona |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | May. 13, 2025 (est.) |
| Last Earnings Release | Mar. 26, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
Edit
| Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others. |
| URL | https://www.journeymedicalcorp.com |
| Investor Relations URL | N/A |
| HQ State/Province | Arizona |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | May. 13, 2025 (est.) |
| Last Earnings Release | Mar. 26, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |